236 related articles for article (PubMed ID: 29903930)
1. Spatial Normalization of
Lilja J; Leuzy A; Chiotis K; Savitcheva I; Sörensen J; Nordberg A
J Nucl Med; 2019 Feb; 60(2):285-291. PubMed ID: 29903930
[TBL] [Abstract][Full Text] [Related]
2. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data.
Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L
J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104
[TBL] [Abstract][Full Text] [Related]
3. Visualization and Quantification of 3-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET Using Variable Depth.
Lilja J; Thurfjell L; Sörensen J
J Nucl Med; 2016 Jul; 57(7):1078-83. PubMed ID: 26912445
[TBL] [Abstract][Full Text] [Related]
4. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
[TBL] [Abstract][Full Text] [Related]
5. Validation of a spatial normalization method using a principal component derived adaptive template for [
Leuzy A; Heurling K; De Santi S; Bullich S; Hansson O; Lilja J
Am J Nucl Med Mol Imaging; 2020; 10(4):161-167. PubMed ID: 32929394
[TBL] [Abstract][Full Text] [Related]
6. Automated PET-only quantification of amyloid deposition with adaptive template and empirically pre-defined ROI.
Akamatsu G; Ikari Y; Ohnishi A; Nishida H; Aita K; Sasaki M; Yamamoto Y; Sasaki M; Senda M
Phys Med Biol; 2016 Aug; 61(15):5768-80. PubMed ID: 27405579
[TBL] [Abstract][Full Text] [Related]
7. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K
Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311
[TBL] [Abstract][Full Text] [Related]
8. A Semiautomated Method for Quantification of F 18 Florbetapir PET Images.
Joshi AD; Pontecorvo MJ; Lu M; Skovronsky DM; Mintun MA; Devous MD
J Nucl Med; 2015 Nov; 56(11):1736-41. PubMed ID: 26338898
[TBL] [Abstract][Full Text] [Related]
9. Parametric imaging of dual-time window [
Heeman F; Yaqub M; Hendriks J; Bader I; Barkhof F; Gispert JD; van Berckel BNM; Lopes Alves I; Lammertsma AA
Neuroimage; 2021 Jul; 234():117953. PubMed ID: 33762215
[TBL] [Abstract][Full Text] [Related]
10. Estimation of amyloid distribution by [
Thal DR; Beach TG; Zanette M; Lilja J; Heurling K; Chakrabarty A; Ismail A; Farrar G; Buckley C; Smith APL
Acta Neuropathol; 2018 Oct; 136(4):557-567. PubMed ID: 30123935
[TBL] [Abstract][Full Text] [Related]
11. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP
Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679
[TBL] [Abstract][Full Text] [Related]
12. Fast and Accurate Amyloid Brain PET Quantification Without MRI Using Deep Neural Networks.
Kang SK; Kim D; Shin SA; Kim YK; Choi H; Lee JS
J Nucl Med; 2023 Apr; 64(4):659-666. PubMed ID: 36328490
[TBL] [Abstract][Full Text] [Related]
13. Adaptive template generation for amyloid PET using a deep learning approach.
Kang SK; Seo S; Shin SA; Byun MS; Lee DY; Kim YK; Lee DS; Lee JS
Hum Brain Mapp; 2018 Sep; 39(9):3769-3778. PubMed ID: 29752765
[TBL] [Abstract][Full Text] [Related]
14. [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease.
Hatashita S; Yamasaki H; Suzuki Y; Tanaka K; Wakebe D; Hayakawa H
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):290-300. PubMed ID: 24085503
[TBL] [Abstract][Full Text] [Related]
15. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
[TBL] [Abstract][Full Text] [Related]
16. A computed tomography-based spatial normalization for the analysis of [18F] fluorodeoxyglucose positron emission tomography of the brain.
Cho H; Kim JS; Choi JY; Ryu YH; Lyoo CH
Korean J Radiol; 2014; 15(6):862-70. PubMed ID: 25469101
[TBL] [Abstract][Full Text] [Related]
17. Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.
Miki T; Shimada H; Kim JS; Yamamoto Y; Sugino M; Kowa H; Heurling K; Zanette M; Sherwin PF; Senda M
Ann Nucl Med; 2017 Apr; 31(3):260-272. PubMed ID: 28181118
[TBL] [Abstract][Full Text] [Related]
18. An exploratory efficacy study of the amyloid imaging agent [(18)F]flutemetamol in Japanese Subjects.
Senda M; Yamamoto Y; Sasaki M; Yamane T; Brooks DJ; Farrar G; McParland B; Heurling K
Ann Nucl Med; 2015 Jun; 29(5):391-9. PubMed ID: 25874747
[TBL] [Abstract][Full Text] [Related]
19. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [
Bucci M; Savitcheva I; Farrar G; Salvadó G; Collij L; Doré V; Gispert JD; Gunn R; Hanseeuw B; Hansson O; Shekari M; Lhommel R; Molinuevo JL; Rowe C; Sur C; Whittington A; Buckley C; Nordberg A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2183-2199. PubMed ID: 33844055
[TBL] [Abstract][Full Text] [Related]
20. Concordance in detecting amyloid positivity between
Cho SH; Choe YS; Kim YJ; Lee B; Kim HJ; Jang H; Kim JP; Jung YH; Kim SJ; Kim BC; Farrar G; Na DL; Moon SH; Seo SW
Sci Rep; 2020 Nov; 10(1):19576. PubMed ID: 33177593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
